Prot# TG1042.06: Phase II Clinical Trial of Intra-Lesional Administration of TG1042 (Adenovirus-Interferon-gamma) in Patients with Relapsing Primary Cutaneous B-Cell Lymphomas

Project: Research project

Project Details

StatusFinished
Effective start/end date12/8/061/20/10

Funding

  • Transgene S.A. (TG1042.06)